Ignacio Garrido-Laguna, Brian M. Wolpin, Wungki Park, Nilofer Saba Azad, Alexander I. Spira, Alexander Starodub, David Sommerhalder, Salman Rafi Punekar, Benjamin Herzberg, Minal A. Barve, Meredith Pelster, Jennifer Brooke Valerin, Joel R Hecht, Rashmi Vora, Aparna Madhukeshwar Hegde, Clay Gustafson, Lin Tao, Sumit Kar, Kevin K. Lin, David S. Hong. "Safety, efficacy, and on-treatment circulating tumor DNA (ctDNA) changes from a phase 1 study of RMC-6236, a RAS(ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.722